Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases: a double-blind, randomized dose-response study (vol 91, pg 1191, 2001)

Citation
Jr. Berenson et al., Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases: a double-blind, randomized dose-response study (vol 91, pg 1191, 2001), CANCER, 91(10), 2001, pp. 1956-1956
Citations number
1
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER
ISSN journal
0008543X → ACNP
Volume
91
Issue
10
Year of publication
2001
Pages
1956 - 1956
Database
ISI
SICI code
0008-543X(20010515)91:10<1956:ZARSEI>2.0.ZU;2-6